SCHEMBL73225

SCHEMBL73225

NCc1nc2ccccc2[nH]1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DDAH1 O94760 1/20 0.66
POLB P06746 1/20 0.66
GAA P10253 1/20 0.61
NPC1 O15118 4/20 0.59
RAB9A P51151 4/20 0.59
BCHE P06276 1/20 0.59
PKM P14618 1/20 0.58
SMN1; SMN2 Q16637 3/20 0.56
TP53 P04637 1/20 0.56
TSHR P16473 1/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2D6 P10635 1/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
MASP2 O00187 1/20 0.55
MEN1 O00255 1/20 0.55
ALDH1A1 P00352 1/20 0.55
NUDT1 P36639 1/20 0.55
KMT2A Q03164 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29450860 1.00 DDAH1 (0.66) DDAH1POLBGAANPC1RAB9A
Hydrochloric Acid SCHEMBL244831 0.98 DDAH1 (0.63) DDAH1POLBGAANPC1RAB9A
Water SCHEMBL8757434 0.98 DDAH1 (0.63) DDAH1POLBGAANPC1RAB9A
Hydrochloric Acid SCHEMBL2674337 0.98 DDAH1 (0.63) DDAH1POLBGAANPC1RAB9A
Hydrochloric Acid SCHEMBL1143206 0.96 PKM (0.64) DDAH1POLBGAANPC1RAB9A
Dipyridyl SCHEMBL28860984 0.87 NPC1 (0.59) DDAH1POLBGAANPC1RAB9A
SCHEMBL524002 0.84 POLB (0.72) DDAH1POLBGAANPC1RAB9A
SCHEMBL29620366 0.84 POLB (0.72) DDAH1POLBGAANPC1RAB9A
SCHEMBL230024 0.83 GAA (0.78) DDAH1POLBGAANPC1RAB9A
SCHEMBL230157 0.83 POLB (0.84) DDAH1POLBGAANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1219 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4731786-A1 COMPOSITIONS AND METHODS FOR NUCLEIC ACID EXTENSION Pacific Biosciences of California, Inc. (US) 2026-04-29 EP claimed
WO-2025006432-A1 COMPOSITIONS AND METHODS FOR NUCLEIC ACID EXTENSION PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) 2025-01-02 WO claimed
US-20240238176-A1 ANTI-POLLUTION ECO-FRIENDLY MATERIAL AND METHOD FOR PREPARING THE SAME Research & Business Foundation Sungkyunkwan University (KR) 2024-07-18 US claimed
CN-115301291-B Heteronuclear bimetallic complex self-assembled MCM-56 molecular sieve catalyst, preparation method and application 万华化学集团股份有限公司 2024-04-09 CN claimed
CN-116836382-A Halogen-free antibacterial polyamide and preparation method thereof 四川轻化工大学 2023-10-03 CN claimed
US-20230210998-A1 METHODS FOR THE CONJUGATION OF ANTHRACYCLINES TO CARBOHYDRATE POLYMERIC CARRIERS SCOTT, JOHN KIM, JR. 2023-07-06 US claimed
WO-2023129652-A1 METHODS FOR THE CONJUGATION OF ANTHRACYCLINES TO CARBOHYDRATE POLYMERIC CARRIERS NAVIDEA BIOPHARMACEUTICALS, INC. (US) 2023-07-06 WO claimed
CN-113087766-B 18 F-labeled targeting activated compound and preparation method and application thereof 江苏省原子医学研究所 2023-04-14 CN claimed
CN-113388004-B Tumor protease activated self-assembly molecular probe and preparation method and application thereof 江苏省原子医学研究所 2023-04-07 CN claimed
CN-115772208-A Granzyme B targeted activation type PET imaging probe and application thereof 江苏省原子医学研究所 2023-03-10 CN claimed
US-5652348-A SOLID SUPPORT MATRIX, IONIZABLE LIGANDS SELECTED RELATIVE TO TARGET COMPOUND MASSEY UNIVERSITY (NZ) 1997-07-29 US claimed
EP-0783366-A1 CHROMATOGRAPHIC RESINS AND METHODS FOR USING SAME MASSEY UNIVERSITY (NZ) 1997-07-16 EP claimed
WO-1996009116-A1 CHROMATOGRAPHIC RESINS AND METHODS FOR USING SAME MASSEY UNIVERSITY (NZ) 1996-03-28 WO claimed
US-5457486-A Thermal printing XEROX CORPORATION (US) 1995-10-10 US claimed
EP-0594656-A1 4-AMINO-3-HYDROXYCARBOXYLIC ACID DERIVATIVES SANDOZ LTD. (CH) 1994-05-04 EP claimed
EP-0578745-A1 PHOSPHORUS CONTAINING COMPOUNDS AS INHIBITORS OF RETROVIRUSES THE UPJOHN COMPANY (US) 1994-01-19 EP claimed
WO-1993001166-A1 4-AMINO-3-HYDROXYCARBOXYLIC ACID DERIVATIVES SANDOZ LTD. (CH) 1993-01-21 WO claimed
WO-1992017490-A1 PHOSPHORUS CONTAINING COMPOUNDS AS INHIBITORS OF RETROVIRUSES THE UPJOHN COMPANY (US) 1992-10-15 WO claimed
EP-0226016-A1 Process for inhibiting hydrogen-induced corrosion of metallic materials BAYER AG (DE) 1987-06-24 EP claimed
US-4662905-A REACTION PRODUCT OF COPPER SALT AND AN IMIDAZOLE, PYRAZOLE, TRIAZOLE, OR TETRAZOLE Itaru Todoriki, Director of Agency of Industrial Science and Technology (JP) 1987-05-05 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230210998-A1 METHODS FOR THE CONJUGATION OF ANTHRACYCLINES TO CARBOHYDRATE POLYMERIC CARRIERS TOP1, ALG1, GNE DDAH1 1481/4885POLB 3640/4885GAA 171/4885
US-20240238176-A1 ANTI-POLLUTION ECO-FRIENDLY MATERIAL AND METHOD FOR PREPARING THE SAME CUTA, EXOSC9, EXOSC10 DDAH1 3519/4885POLB 9/4885GAA 145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.